
LGVN
Healthcare · Biotechnology · $8.4M market cap
$2.49-0.48 (-16.2%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -13.3% over 90 days · 30-day revisions 1 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -1.70 | -1.91 | -12.4% |
| Aug 12, 2026 | After the close | -0.19 | -0.19 | 0.0% |
| May 13, 2026 | After the close | -0.17 | -0.19 | -11.8% |
| Mar 18, 2026 | Time not confirmed | -3.67 | -2.20 | +40.0% |
| Nov 4, 2025 | After the close | -0.26 | -0.39 | -50.0% |
| Aug 13, 2025 | After the close | -0.35 | -0.33 | +5.7% |
| May 8, 2025 | After the close | -0.33 | -0.34 | -3.0% |
| Feb 28, 2025 | Time not confirmed | -0.20 | -0.27 | -35.0% |
| Nov 12, 2024 | After the close | -0.44 | -0.34 | +22.7% |
| Aug 14, 2024 | After the close | -0.87 | -1.83 | -110.3% |
| May 14, 2024 | After the close | -2.00 | -1.61 | +19.5% |
| Feb 27, 2024 | After the close | -2.05 | -2.50 | -22.0% |
| Nov 9, 2023 | After the close | -2.40 |
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a…
| -2.80 |
| -16.7% |
| Aug 11, 2023 | Before the open | -2.47 | -2.70 | -9.3% |
| May 12, 2023 | Before the open | -0.21 | -0.22 | -4.8% |
| Mar 10, 2023 | Before the open | -2.00 | -2.10 | -5.0% |
| Nov 14, 2022 | Before the open | -2.20 | -2.50 | -13.6% |
| Aug 12, 2022 | Before the open | -2.27 | -2.70 | -18.9% |
| May 13, 2022 | Before the open | -2.25 | -1.70 | +24.4% |
| Mar 11, 2022 | Before the open | -0.25 | -0.20 | +20.0% |
| Dec 22, 2021 | After the close | — | -0.25 | — |
| Aug 13, 2021 | Time not confirmed | — | -0.26 | — |
| May 14, 2021 | Time not confirmed | — | -0.18 | — |
| Jan 19, 2021 | Time not confirmed | — | -0.03 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | -0.66 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -0.06 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.08 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.23 | — |